  <script type="text/javascript">
    $(function () {

    $( "#soutien_next" ).click(function() {

        /*console.log($( this ).get());*/
        target = $(this).attr( "alt" );
        window.parent.showTab(target);

    });

  });//end document.ready
</script>
<div class="innerContentFrame">
   <table style="width:100%;" >
      <tr valign="top">
        <td style="padding: 0 0 10px 45px;width:650px;"><img src="images/bannerE.jpg" width="600" height="322" align="left" alt="Herpes Zoster banner"/>
        </td>
      </tr>

      <tr>
        <td style="width:650px;vertical-align:top;padding:0;margin:0;" colspan="2">
              <table align="left" style="margin:5px 0 0 47px;width:598px;border: 1px solid #008000;" class="plain">
                  <tr>
                    <td style="padding: 20px 0 0 10px;"><span class="subTitle">Presenters</span>
                    </td>
                  </tr>
                  <tr>
                      <td style="padding: 15px 0 0 15px;"><a href="/programs/CCC_Symposium/pdf/Declaration_of_Conflict_of_Interest_Gregory_Lip.pdf" target="_blank"><span class="doc_name accred_reqs">Gregory YH Lip, MD, FRCP, DFM, FACC, FESC</span></a><br>Professor of Cardiovascular Medicine, University of Birmingham, UK;<br>Adjunct Professor of Cardiovascular Sciences, Thrombosis Research Unit, Aalborg University, Denmark;<br>Visiting Professor of Haemostasis Thrombosis & Vascular Sciences, Aston University, Birmingham, UK;<br>Visiting Professor of Cardiology, University of Belgrade, Serbia</td>
                  </tr>
                  <tr>
                     <td style="padding: 15px 0 0 15px;"><a href="/programs/CCC_Symposium/pdf/Declaration_of_Conflict_of_Interest_Brent_Mitchell.pdf" target="_blank"><span class="doc_name accred_reqs">L. Brent Mitchell, MD, FRCPC</span></a><br>Professor, Department of Cardiac Sciences<br>Calgary Zone, Alberta Health Services and<br>Libin Cardiovascular Institute of Alberta<br>Calgary, Alberta, Canada</td>
                  </tr>
                  <tr>
                      <td style="padding: 15px 0 20px 15px;"><a href="/programs/CCC_Symposium/pdf/Declaration_of_Conflict_of_Interest_Paul_Dorian.pdf" target="_blank"><span class="doc_name accred_reqs">Paul Dorian MD, MSc, FRCP(C)</span></a><br>Dexter H.C. Man Chair in Cardiology<br>Department Director, Division of Cardiology<br>Staff Cardiac Electrophysiologist<br>St. Michaelâ€™s Hospital<br>Professor of Medicine<br>Division of Cardiology and<br>Division of Clinical Pharmacology<br>University of Toronto<br>Toronto, Ontario</td>
                  </tr>
              </table>

            <div class="fieldset_frame" style="clear:both;padding-top:15px;padding-left:45px;line-height:20px;">
              <fieldset style="width:578px; padding-top:15px;">
                <span class="subTitle">Learning Objectives</span><br><br>At the end of this session, participants will be able to:
                <ul class="defaultUL">
                  <li>Integrate recent data from randomized trials and national and international databases and registries on the real-world use, effectiveness and safety of oral anticoagulants in patients with AF.</li>
                  <li>Consider additional treatment scenarios such as AF with concomitant coronary artery disease and recognize the role of various antithrombotic agents for stroke prevention in such settings.</li>
                  <li>Individualize antithrombotic therapy and practice effective DOAC usage in patients with special considerations, whilst balancing risk of bleeding with the benefit of stroke prevention.</li> 
                </ul></fieldset>
            </div>

          <div class="fieldset_frame" style="clear:both;padding-top:15px;padding-left:45px;line-height:20px;">
            <fieldset style="width:578px; padding-top:15px;">
              <span class="subTitle">Accreditation</span>
                <p>This online program is an accredited self-directed learning activity under Section 1 as defined by the Royal College of Physicians & Surgeons of Canada for the Maintenance of Certification program. It is approved by the Canadian Cardiovascular Society for a maximum of 1 credit. This accredited symposium is co-developed with the Canadian Cardiovascular Society and BMS / Pfizer Alliance and is planned to ensure the evidence presented is valid, objective and balanced.</p>
                <p>Through an agreement between the Royal College of Physicians and Surgeons of Canada and the American Medical Association, physicians may convert Royal College MOC credits to AMA PRA Category 1 Credits<sup>TM</sup></p>
              </fieldset>
          </div>
        </td>
        </tr>
    </table>
</div>